A practical approach for evaluating population and individual bioequivalence
β Scribed by A. Lawrence Gould
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 146 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0277-6715
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Pharmaceutical companies conduct bioequivalence studies to demonstrate that a new formulation of a drug product ('Test') is sufficiently similar in rate and extent of absorption to the current formulation ('Reference'). Such similarity permits the efficacy and safety results for the Reference formul
The two-period cross-over design with two sequences of drug administration is a standard experimental design when bioequivalence of one test formulation is to be assessed in comparison with a reference formulation. Previously, an approach based on Fieller's confidence interval has been presented for